HTB

2017

Hepatology – a clinical textbook (8th edition, 2017)

Online video: PrEP 17 – The coming of age of PrEP

Online video: PrEP 17 – The coming of age of PrEP

HIV.gov – AIDS.gov relaunched

May/June 2017: Volume 18 Number 5/6

March/April 2017: Volume 18 Number 3/4

March/April 2017: Volume 18 Number 3/4

i-Base appeal: we need your help…

23rd Annual Conference of BHIVA, 4-7 April 2017, Liverpool

Drop in HIV incidence in gay men: frequent testing, early ART and PrEP

Prompt/early ART: Dean Street pilot project reports 75% uptake

Potential for phylogenetic analysis to show direction of HIV transmission

Community presentations: dental care, HIV awareness and access to formula milk

Initiatives for earlier HIV diagnosis: opt-out ER and home testing

No new HIV cases in 398 people using PrEP at Dean Street clinic

Other selections and webcasts

24th Conference on Retroviruses and Opportunistic Infections (CROI 2017), 13-16 February 2017, Seattle

Dose reduction potential of nanoparticle ARV formulations confirmed in humans

VRC01 in HIV-exposed newborns: first results support monthly injections for those at risk through breastfeeding

Raltegravir pharmacokinetic targets met in high-risk HIV-exposed infants

Tenofovir alafenamide exposure is modestly higher in children than adults

New HIV diagnoses in children in UK and Ireland continue to decline

World Health Organisation paediatric dosing tool

Pre-ART drug resistance in rural South Africa but limited clinical impact with good adherence

Immune-based therapy canakinumab reduces inflammatory markers in HIV positive people on ART

Significant interaction between once-weekly isoniazid/rifapentine and daily dolutegravir: study stopped due to toxicity

Increased risk of IRIS with integrase inhibitors reported in two studies

Breakthrough for treating XDR-TB and ameliorating TB-IRIS

PrEP in pregnancy does not increase poor birth outcomes

HIV cure research and basic science: capsules from CROI 2017

EACS guidelines: seven translations now online (2017)

Flagging the HIV reservoir: a potential new marker for CD4 cells hiding HIV

PrEP approved in Scotland but not in Wales

HIV: is victory in sight? – Brighton talk

Introduction to cost-effectiveness analysis for infectious diseases

Clinical management of HIV: EACS online course

Community report: RITA: dyslipidemia with HIV

January/February 2017: Volume 18 Number 1/2

Pocket guides: A7 concertina leaflets

24th Conference on Retroviruses and Opportunistic Infections (CROI 2017), 13-16 February 2017, Seattle

Pharmacokinetics and full phase 2 results for bictegravir, a new integrase inhibitor

New NNRTI doravirine is non-inferior to darunavir/r in phase 3 treatment naive study

NRTI GS-9131 resurfaces at CROI 2017: in vitro sensitivity to nuke-resistant HIV

Dolutegravir exposure increases when fixed dose combination tablets are crushed

Pharmacokinetics, safety and efficacy of dolutegravir in very young children

Efavirenz, tenofovir and emtricitabine associated with fewest adverse birth outcomes in Botswana

Adverse pregnancy outcomes and risk factors in the PROMISE trial

Women on lopinavir/ritonavir-based regimens at conception at higher risk of preterm delivery in UK study

No increase in adverse birth outcomes with maternal TDF/FTC in US study

Dolutegravir monotherapy studies halted due to integrase resistance: dual therapy studies continue

No evidence of accelerated brain ageing in HIV positive people on effective ART

Acute infection with wild-type HIV on PrEP with good drug levels

Fit for purpose: antiretroviral treatment optimisation Feb 2017

Seattle-lite: pre-conference workshops – watch online

US Stribild label updated: new indication to include patients age 12 and older

Option to take crushed Stribild tablets with food or enteral nutrition

ART adherence in first four months predicts long-term viral suppression in 12-year study

Sutezolid added to MPP as potential TB drug

Pregnancy common in ART trials in sub-Saharan Africa despite exclusion criteria

Drug-drug interactions and hormone therapy for gender transitioning

New NICE/PHE testing guidelines (2017)

WHO guidelines on HIV self-testing and partner notification (2017)

Effects of ART initiation on human papillomavirus antibody response

Rosuvastatin for chronic obstructive pulmonary disease (COPD) in people with HIV

Soluble CD163 as a marker of CMV mediated immune activation

Post navigation